相似文献
1
How does BAFF activate B cells in patients with autoimmune diseases?
Arthritis Res Ther. 2012 Feb 24;14(1):106. doi: 10.1186/ar3729.
2
Regulatory mechanisms for the production of BAFF and IL-6 are impaired in monocytes of patients of primary Sjögren's syndrome.
Arthritis Res Ther. 2011;13(5):R170. doi: 10.1186/ar3493. Epub 2011 Oct 21.
3
Increase of Intracellular BAFF in B Cells of Sjögren's Patients Is Not Affected by Decrease of BAFFR.
Acta Medica (Hradec Kralove). 2015;58(1):25-31. doi: 10.14712/18059694.2015.88.
4
Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome.
Arthritis Rheum. 2007 Apr;56(4):1134-44. doi: 10.1002/art.22458.
5
Expression of BAFF and BAFF receptors in primary Sjögren's syndrome patients with ectopic germinal center-like structures.
Clin Exp Med. 2020 Nov;20(4):615-626. doi: 10.1007/s10238-020-00637-0. Epub 2020 Jun 6.
6
B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome.
Arthritis Res Ther. 2006;8(2):R51. doi: 10.1186/ar1912. Epub 2006 Feb 28.
7
Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren's syndrome.
Rheumatology (Oxford). 2015 Aug;54(8):1429-34. doi: 10.1093/rheumatology/kev005. Epub 2015 Mar 3.
8
A role of the macrophage in Sjögen's syndrome?
Scand J Rheumatol. 2003;32(4):255. doi: 10.1080/03009740310003785.
9
Targeting the splicing of mRNA in autoimmune diseases: BAFF inhibition in Sjögren's syndrome as a proof of concept.
Mol Ther. 2014 Apr;22(4):821-7. doi: 10.1038/mt.2013.275. Epub 2013 Dec 5.
10
[An update on primary Gougerot-Sjögren's syndrome in 1995].
Ann Pathol. 1996;16(1):11-9.
引用本文的文献
1
Sarcoidosis and Cancer: A Complex Relationship.
Front Med (Lausanne). 2020 Nov 24;7:594118. doi: 10.3389/fmed.2020.594118. eCollection 2020.
本文引用的文献
1
Regulatory mechanisms for the production of BAFF and IL-6 are impaired in monocytes of patients of primary Sjögren's syndrome.
Arthritis Res Ther. 2011;13(5):R170. doi: 10.1186/ar3493. Epub 2011 Oct 21.
2
Pathogenesis of Sjögren's syndrome and therapeutic consequences.
Curr Opin Rheumatol. 2010 Sep;22(5):471-7. doi: 10.1097/BOR.0b013e32833c36c5.
3
Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus.
Nat Immunol. 2009 Jul;10(7):778-85. doi: 10.1038/ni.1741. Epub 2009 May 31.
4
The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders.
Ann Rheum Dis. 2009 Mar;68(3):337-44. doi: 10.1136/ard.2007.085910. Epub 2008 Apr 23.
5
B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndrome.
Scand J Immunol. 2008 Feb;67(2):185-92. doi: 10.1111/j.1365-3083.2007.02049.x.
6
Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome.
Arthritis Rheum. 2007 Apr;56(4):1134-44. doi: 10.1002/art.22458.
7
Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.
Ann Rheum Dis. 2007 Jun;66(6):790-7. doi: 10.1136/ard.2006.065656. Epub 2006 Dec 21.
8
B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome.
Arthritis Res Ther. 2006;8(2):R51. doi: 10.1186/ar1912. Epub 2006 Feb 28.
9
Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome.
J Pathol. 2004 Apr;202(4):496-502. doi: 10.1002/path.1533.
10
Synthesis and release of B-lymphocyte stimulator from myeloid cells.
Blood. 2001 Jan 1;97(1):198-204. doi: 10.1182/blood.v97.1.198.
Zotero 插件